Caisse Des Depots ET Consignations Has $5.51 Million Position in Cardinal Health, Inc. $CAH

Key Points

• Caisse Des Dépôts et Consignations cut its stake in Cardinal Health by 20.8% in Q4, selling 7,037 shares and leaving a 26,814‑share position worth $5.51 million.
• Cardinal Health beat Q3 non‑GAAP EPS expectations and raised FY‑2026 guidance to $10.70–$10.80, but revenue missed estimates and GAAP results were weakened by a $184 million goodwill impairment, producing mixed market reaction.
• About 87.17% of CAH is owned by institutions—major investors like Vanguard and Wellington increased holdings—and the company added $250M in buybacks (FY26 repurchases now $1.0B) while reducing debt, supporting the stock amid short‑term volatility.

Caisse Des Depots ET Consignations cut its position in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 20.8% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 26,814 shares of the company's stock after selling 7,037 shares during the quarter. Caisse Des Depots ET Consignations' holdings in Cardinal Health were worth $5,510,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Vanguard Group Inc. raised its position in shares of Cardinal Health by 2.0% in the 4th quarter. Vanguard Group Inc. now owns 31,441,258 shares of the company's stock valued at $6,461,179,000 after buying an additional 617,775 shares in the last quarter. Wellington Management Group LLP increased its position in Cardinal Health by 153.2% during the 3rd quarter. Wellington Management Group LLP now owns 5,804,090 shares of the company's stock worth $911,010,000 after purchasing an additional 3,511,579 shares in the last quarter. Bank of America Corp DE increased its position in Cardinal Health by 3.2% during the 3rd quarter. Bank of America Corp DE now owns 3,592,775 shares of the company's stock worth $563,922,000 after purchasing an additional 111,582 shares in the last quarter. Invesco Ltd. increased its position in Cardinal Health by 14.7% during the 3rd quarter. Invesco Ltd. now owns 3,483,207 shares of the company's stock worth $546,724,000 after purchasing an additional 445,425 shares in the last quarter. Finally, Victory Capital Management Inc. increased its position in Cardinal Health by 44.9% during the 3rd quarter. Victory Capital Management Inc. now owns 2,284,115 shares of the company's stock worth $352,165,000 after purchasing an additional 707,495 shares in the last quarter. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Cardinal Health News Summary

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Q3 non‑GAAP earnings beat estimates and company raised FY‑2026 guidance to $10.70–$10.80, above consensus — the core bullish catalyst. PR Newswire: Q3 Results & Outlook
• Positive Sentiment: Company executed $250M additional share repurchase (bringing FY26 repurchases to $1.0B) and reduced debt — shareholder‑friendly actions that support the share price. PR Newswire: Buybacks & Debt Reduction
• Neutral Sentiment: Wells Fargo cut its price target from $256 to $245 but kept an "overweight" rating, signaling continued analyst confidence despite the trim. Benzinga: Wells Fargo PT Change
• Neutral Sentiment: Full earnings call and transcripts are available for investors who want details on segment performance and management commentary. Yahoo Finance: Earnings Transcript Seeking Alpha: Call Transcript
• Negative Sentiment: Revenue missed expectations ($60.9B reported vs. ~$62.1B est.), which prompted media coverage and short‑term selling pressure despite the EPS beat. Benzinga: Revenue Miss Coverage
• Negative Sentiment: GAAP results were weaker: GAAP operating earnings and GAAP EPS declined, driven in part by a $184M pre‑tax goodwill impairment in the Navista & ION reporting unit — a one‑time charge that reduces headline profitability. PR Newswire: Goodwill Impairment
• Negative Sentiment: Several outlets highlighted the "mixed" nature of the report (EPS/guidance vs. revenue/GAAP weakness), which can increase volatility and keep some investors on the sidelines. CNBC: Mixed Results Coverage

Cardinal Health Stock Performance

Shares of NYSE CAH opened at $195.13 on Friday. Cardinal Health, Inc. has a 52-week low of $137.75 and a 52-week high of $233.60. The firm has a 50 day moving average price of $213.73 and a two-hundred day moving average price of $205.46. The stock has a market cap of $45.92 billion, a P/E ratio of 28.08, a price-to-earnings-growth ratio of 1.19 and a beta of 0.53.

Cardinal Health (NYSE:CAH - Get Free Report) last announced its quarterly earnings results on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.79 by $0.38. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The firm had revenue of $60.94 billion during the quarter, compared to analysts' expectations of $62.10 billion. During the same period in the prior year, the company posted $2.35 EPS. The company's revenue was up 11.0% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Analysts predict that Cardinal Health, Inc. will post 10.79 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, April 15th. Stockholders of record on Wednesday, April 1st were paid a $0.5107 dividend. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date of this dividend was Wednesday, April 1st. Cardinal Health's dividend payout ratio is currently 29.35%.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on CAH shares. Barclays upped their price objective on shares of Cardinal Health from $243.00 to $258.00 and gave the stock an "overweight" rating in a research report on Tuesday, February 24th. William Blair started coverage on shares of Cardinal Health in a research report on Tuesday. They set an "outperform" rating for the company. Mizuho upped their price objective on shares of Cardinal Health from $222.00 to $235.00 and gave the stock an "outperform" rating in a research report on Friday, February 6th. TD Cowen upped their price objective on shares of Cardinal Health from $251.00 to $255.00 and gave the stock a "buy" rating in a research report on Friday. Finally, Leerink Partners reiterated an "outperform" rating and set a $275.00 price objective on shares of Cardinal Health in a research report on Monday, March 9th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat, Cardinal Health has a consensus rating of "Moderate Buy" and a consensus target price of $243.67.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company's core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.